QCM
AVXL icon

Quantinno Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Quantinno Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Sell
12,733
-41,814
-77% -$124K ﹤0.01% 3424
2026
Q1 		$167K Buy
54,547
+8,836
+19% +$38.3K ﹤0.01% 3218
2025
Q4 		$163K Buy
45,711
+11,437
+33% +$70.1K ﹤0.01% 3086
2025
Q3 		$305K Buy
34,274
+6,986
+26% +$70.9K ﹤0.01% 2441
2025
Q2 		$252K Buy
27,288
+4,279
+19% +$36.5K ﹤0.01% 2162
2025
Q1 		$197K Buy
+23,009
New +$217K ﹤0.01% 1891

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantinno Capital Management's AVXL Position: Q2 2026 in Review

Quantinno Capital Management reduced its Anavex Life Sciences (AVXL) stake by 77% in Q2 2026, selling an estimated $124K and leaving 12,733 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3424.

Quantinno Capital Management first reported a position in AVXL in Q1 2025 and has held it in 6 quarters since. The position peaked at $305K in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Quantinno Capital Management held 12,733 shares of Anavex Life Sciences worth $33K as of Q2 2026.
  • Quantinno Capital Management sold 41,814 Anavex Life Sciences shares in Q2 2026, an estimated $124K.
  • Anavex Life Sciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3424 holding.
  • Quantinno Capital Management first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Quantinno Capital Management's Anavex Life Sciences position peaked at $305K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.